Impact of CHEK2 germline variants on haematological malignancy risk and outcomes of allogeneic HSCT.
作者信息
Lahtinen Atte K, Karu Maarja, Koski Jessica R, Ritari Jarmo, Hyvärinen Kati, Koskela Satu, Nihtilä Julia, Partanen Jukka, Vettenranta Kim, Koskenvuo Minna, Niittyvuopio Riitta, Salmenniemi Urpu, Itälä-Remes Maija, Jahnukainen Kirsi, Kilpivaara Outi, Wartiovaara-Kautto Ulla
机构信息
Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Department of Medical and Clinical Genetics, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
出版信息
Br J Haematol. 2025 Jun 12;207(2):636-41. doi: 10.1111/bjh.20196.
Abstract
摘要
Zotero 插件